Yoshinoya may remove 'gyudon' beef bowls from menu

Yoshinoya may remove 'gyudon' beef bowls from menu

TOKYO, Japan - Shuji Abe, president of fast-food chain Yoshinoya D&C Co. tells reporters at the Tokyo Stock Exchange on Dec. 30 that the company will remove its ''gyudon'' beef bowls from the menu if Japan's current ban on U.S. beef imports continues.

  • Product Code
  • ILEA001100650
  • Registered date
  • 2003/12/30 00:00:00
  • Credit
  • Kyodo / Kyodo News Images
  • Media source
  • 2003 Kyodo News
  • Media size
  • 1864 × 1079 pixel
  • Resolution
  • dpi
  • Deployment size
  • 635.74(KB)*
  • Special instruction

*File size when opened in Photoshop, etc.

Similar Images & Videos
    Tokyo Metro shares debut on Tokyo bourse

    Tokyo Metro shares debut on Tokyo bourse

    President Akiyoshi Yamamura (R) of Tokyo Metro Co., Asia's oldest subway operator, speaks during a press conference in Tokyo on Oct. 23, 2024, after the company was listed on the Tokyo Stock Exchange's top-tier Prime Market the same day.
      Tokyo Metro shares debut on Tokyo bourse

      Tokyo Metro shares debut on Tokyo bourse

      President Akiyoshi Yamamura (front, 5th from L) of Tokyo Metro Co., Asia's oldest subway operator, poses for photos with the company's executives at the Tokyo Stock Exchange on Oct. 23, 2024, after the company was listed on the bourse's top-tier Prime Market the same day.
        Tokyo Metro shares debut on Tokyo bourse

        Tokyo Metro shares debut on Tokyo bourse

        President Akiyoshi Yamamura of Tokyo Metro Co., Asia's oldest subway operator, speaks during a press conference in Tokyo on Oct. 23, 2024, after the company was listed on the Tokyo Stock Exchange's top-tier Prime Market the same day.
          Tokyo Metro shares debut on Tokyo bourse

          Tokyo Metro shares debut on Tokyo bourse

          President Akiyoshi Yamamura (C, front) of Tokyo Metro Co., Asia's oldest subway operator, poses for photos with the company's executives at the Tokyo Stock Exchange on Oct. 23, 2024, after the company was listed on the bourse's top-tier Prime Market the same day.
            Tokyo Metro shares debut on Tokyo bourse

            Tokyo Metro shares debut on Tokyo bourse

            President Akiyoshi Yamamura of Tokyo Metro Co., Asia's oldest subway operator, speaks during a press conference in Tokyo on Oct. 23, 2024, after the company was listed on the Tokyo Stock Exchange's top-tier Prime Market the same day.
              Daihatsu Motor President Okudaira

              Daihatsu Motor President Okudaira

              Daihatsu Motor Co. President Soichiro Okudaira (C) bows at a press conference in Tokyo on Dec. 20, 2023, as he apologizes over his company's improper vehicle tests. The Toyota Motor Corp. subsidiary announced the same day it will stop all shipments in domestic and overseas markets as most of its car models are affected.
                Daihatsu Motor President Okudaira

                Daihatsu Motor President Okudaira

                Daihatsu Motor Co. President Soichiro Okudaira (C) speaks about his company's improper vehicle tests at a press conference in Tokyo on Dec. 20, 2023. The Toyota Motor Corp. subsidiary announced the same day that it will stop all shipments in domestic and overseas markets as most of its car models are affected.
                  Toshiba Corp. to delist from Tokyo Stock Exchange

                  Toshiba Corp. to delist from Tokyo Stock Exchange

                  Photo shows Toshiba Corp.'s closing price (top, C) at 4,590 yen on an electronic signboard at the Tokyo Stock Exchange on Dec. 19, 2023, the last day of trading on the exchange. The Japanese conglomerate will be delisted from the bourse on Dec. 20, ending its 74-year history as a public company.
                    U.S. regulators OK Alzheimer's drug developed by Japan's Eisai

                    U.S. regulators OK Alzheimer's drug developed by Japan's Eisai

                    Japanese pharmaceutical maker Eisai Co. CEO Haruo Naito holds a press conference in Tokyo on Jan. 7, 2023, a day after the U.S. Food and Drug Administration approved lecanemab, an Alzheimer's drug developed by his company and U.S. firm Biogen Inc. for treatment in the early stage of the fatal, brain-robbing disease.
                      U.S. regulators OK Alzheimer's drug developed by Japan's Eisai

                      U.S. regulators OK Alzheimer's drug developed by Japan's Eisai

                      Japanese pharmaceutical maker Eisai Co. CEO Haruo Naito holds a press conference in Tokyo on Jan. 7, 2023, a day after the U.S. Food and Drug Administration approved lecanemab, an Alzheimer's drug developed by his company and U.S. firm Biogen Inc. for treatment in the early stage of the fatal, brain-robbing disease.